| 注册
首页|期刊导航|中国医学前沿杂志(电子版)|玻璃体腔注射雷珠单抗治疗糖尿病性黄斑水肿临床效果分析

玻璃体腔注射雷珠单抗治疗糖尿病性黄斑水肿临床效果分析

刘璐 陈明 柴广睿

中国医学前沿杂志(电子版)2016,Vol.8Issue(4):85-87,3.
中国医学前沿杂志(电子版)2016,Vol.8Issue(4):85-87,3.

玻璃体腔注射雷珠单抗治疗糖尿病性黄斑水肿临床效果分析

Clinical effect analysis of intravitreal injection of ranibizumab in the treatment of diabetic macular edema

刘璐 1陈明 1柴广睿1

作者信息

  • 1. 中国医科大学附属盛京医院 眼科,沈阳110004
  • 折叠

摘要

Abstract

ObjectiveTo observe the clinical effect of intravitreal injection of ranibizumab in the treatment of diabetic macular edama (DME).MethodA total of 36 patients (36 eyes) diagnosed DME from January 2015 to August 2015 in our hospital were selected as the research objects, and received intravitreal injection of ranibizumab. Dectected and compared the best corrected visual acuity, foveal retinal thinckness, subfoveal choroidal thinckness before and after treatment.Result1 month after treatment, the best corrected visual acuity had obviously increased (P<0.05), and the foveal retinal thickness as well as subfoveal choroidal thinckness had significantly decreased (P<0.05).ConclusionIntravitreal injection of ranibizumab in the treatment of DME can improve the best corrected visual auity of DME patients, and can relieve macular edema without series complications. The thickness of foveal retinal thickness may be a clinical index to evaluate the prognosis.

关键词

雷珠单抗/糖尿病性黄斑水肿/视网膜病变

Key words

Ranibizumab/Diabetic macular edema/Retinopathy

引用本文复制引用

刘璐,陈明,柴广睿..玻璃体腔注射雷珠单抗治疗糖尿病性黄斑水肿临床效果分析[J].中国医学前沿杂志(电子版),2016,8(4):85-87,3.

中国医学前沿杂志(电子版)

OACSTPCD

1674-7372

访问量0
|
下载量0
段落导航相关论文